Wall Street Zen Downgrades Astrotech (NASDAQ:ASTC) to Strong Sell

Posted by Bonnie Powley on Jul 22nd, 2026

Astrotech (NASDAQ:ASTC – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a report released on Monday.

Separately, Weiss Ratings raised shares of Astrotech from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, May 27th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Astrotech has an average rating of “Sell”.

Check Out Our Latest Report on ASTC

Astrotech Trading Down 0.7%

ASTC opened at $7.55 on Monday. The company has a market cap of $13.59 million, a price-to-earnings ratio of -0.90 and a beta of 4.77. The stock has a fifty day simple moving average of $14.43 and a two-hundred day simple moving average of $7.12. Astrotech has a 12-month low of $1.91 and a 12-month high of $68.85.

Astrotech (NASDAQ:ASTC – Get Free Report) last announced its earnings results on Wednesday, May 13th. The aerospace company reported ($2.25) EPS for the quarter. The business had revenue of $0.34 million for the quarter. Astrotech had a negative net margin of 1,397.82% and a negative return on equity of 81.85%.

Hedge Funds Weigh In On Astrotech

Hedge funds have recently bought and sold shares of the company. J. Safra Sarasin Holding AG purchased a new stake in Astrotech during the 1st quarter valued at about $140,000. Susquehanna International Group LLP purchased a new position in Astrotech in the third quarter worth about $66,000. Finally, DRW Securities LLC raised its holdings in Astrotech by 168.5% in the fourth quarter. DRW Securities LLC now owns 31,464 shares of the aerospace company’s stock worth $109,000 after buying an additional 19,747 shares during the last quarter. Institutional investors own 24.35% of the company’s stock.

About Astrotech

(Get Free Report)

Astrotech Corp. (NASDAQ: ASTC) is a technology commercialization company headquartered near Austin, Texas. The firm sources early-stage innovations from government and university research programs—most notably from NASA—and advances them toward commercial readiness. Astrotech’s core mission is to bridge the gap between federally funded R&D and industrial applications across the life sciences and renewable energy sectors.

In its life sciences division, Astrotech has focused on mass spectrometry-based analytical instruments and diagnostic platforms.